Author:
Seitz J.,von Au A.,Sohn C.,Marme F.,Schneeweiss A.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Amant F, Van Calsteren K, Halaska MJ, Gziri MM, Hui W, Lagae L, Willemsen MA, Kapusta L, Van Calster B, Wouters H et al (2012) Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study. Lancet Oncol 13:256–264
2. Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, Han S, Gziri MM, Peccatori F, Rob L et al (2015) Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med 373:1824–1834
3. Avilés A, Neri N (2001) Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero. Clin Lymphoma 2:173–177
4. Bamdad S, Bamdad M, Khanlari M, Daneshbod Y, Khademi B (2017) Teratogenic effects of Intravitreal injection of bevacizumab in a pregnant rat model. Iran J Pharm Res 16:670–676
5. Barbieri V, Sanpaolo P, Genovesi D (2011) Interval between breast-conserving surgery and start of radiation therapy in early-stage breast cancer is not predictive of local recurrence: a single-institution experience. Clin Breast Cancer 11:114–120